证券记录 · 已归档季度
PODD
Insulet Corp. · Healthcare · Medical - Devices
18被追踪持有人
0Δ持有人
8.60M持有股份
$2.00B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -14.6% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | -1 | 427.34K | $55.53M | n/a | −1 |
| Q2 2026 | 158 | 0 | 52.88M | $8.06B | +7 | −8 |
| Q1 2026 | 162 | -3 | 53.76M | $11.28B | +2 | −6 |
| Q4 2025 | 164 | +1 | 61.46M | $17.44B | +2 | n/a |
| Q3 2025 | 24 | +1 | 35.22M | $10.87B | +1 | −1 |
| Q2 2025 | 21 | -2 | 34.19M | $10.74B | n/a | −2 |
| Q1 2025 | 20 | +1 | 10.99M | $2.88B | +1 | n/a |
| Q4 2024 | 19 | 0 | 11.49M | $3.00B | +1 | −1 |
| Q3 2024 | 18 | 0 | 8.60M | $2.00B | +1 | −1 |
| Q2 2024 | 18 | n/a | 10.07M | $2.03B | n/a | n/a |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 2.28M | +20.7% | $529.67M | 0.4% | ▲ Add | 2 | SEC ↗ ×4 |
| 2 | Geode Capital Management ✦ (被动) | 1.74M | +1.3% | $403.34M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Citadel Advisors ✦ | 990.49K | -34.3% | $230.54M | 0.2% | ▼ Trim | 2 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (被动) | 887.45K | -7.0% | $206.55M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | PRIMECAP Management ✦ | 552.10K | -4.8% | $128.50M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 6 | Marshall Wace ✦ | 375.40K | -24.2% | $87.37M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 7 | Fisher Asset Management ✦ | 351.10K | +0.9% | $81.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 336.96K | -67.4% | $78.43M | 0.0% | ▼ Trim | 2 | SEC ↗ ×10 |
| 9 | Adage Capital Partners ✦ | 257.32K | +195.1% | $59.89M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 201.98K | -50.5% | $47.01M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 11 | Millennium Management ✦ | 172.69K | -23.6% | $40.19M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 12 | Capital World Investors ✦ | 168.00K | 0.0% | $39.10M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 123.39K | -31.1% | $28.62M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 14 | Renaissance Technologies ✦ | 109.09K | 新增 | $25.39M | 0.0% | New | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 39.11K | -56.5% | $9.10M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 11.14K | -22.7% | $2.59M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 4.34K | -55.2% | $1.01M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 1.16K | -50.1% | $269,525 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Renaissance Technologies | $25.39M | 0.0% |
已清仓
| Point72 Asset Management | $74.15M | 曾为 0.2% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 779 持有人, 69.27M 股份, $13.82B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
Aug 21
McEvoy Ashley
Officer, Director · President and CEO · 1.10K 股 @ 147.47 · $162,217
公开市场卖出 (S)
在我们的覆盖窗口内无内部人士公开市场卖出记录。
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 06
SC 13G/A: FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据